Danny Filiatreault

Novartis (United States)

Papers

1

Total Citations

17

H-Index

1

About

Danny Filiatreault is a researcher at the forefront of structural biology and microfluidics, with a focus on accelerating drug discovery through innovative crystallographic methods. His most notable contribution is the development of a capillary-based microfluidic device that enables primary high-throughput room-temperature crystallographic screening, a breakthrough detailed in his 2021 paper, which has garnered 17 citations. This work introduces ultra-thin microfluidic devices composed of a UV-curable polymer, patterned via cleanroom photolithography, to streamline small-molecule-compound screening using protein crystals. By enabling room-temperature X-ray crystallography, Filiatreault’s approach reduces the time and complexity of traditional screening methods, offering a practical solution for structural biology labs. His achievements highlight a commitment to bridging engineering and biochemistry, with potential impacts on pharmaceutical development and structural genomics. Filiatreault’s research is particularly valuable for students and researchers seeking efficient, scalable tools for protein–ligand interaction studies, positioning him as an emerging voice in the integration of microfabrication and crystallographic science.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screening
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Novartis (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago